Dear colleagues On behalf of the organising committee, it is our pleasure to invite you to participate in the 46th Annual Congress of the SASBCP in association with the Dept. of Family Medicine (UP) and TOXSA to be held in Pretoria, South Africa from the 29th of September to the 2nd of October 2012 under the theme: “Medical Science – Current Clinical Perspectives”.
Dear International and National Congress Delegates.
On behalf of the organising committee at the Dept of Pharmacology, University of Pretoria, it is our pleasure to announce to you and also to extend an invitation to you to participate in the annual Congressof the South African Society for Basic and Clinical Pharmacology in association with the Dept. of Family Medicine, School of Medicine, University of Pretoria from 29th of September – 2nd of October 2012 under the theme: “Medical Science – Current Clinical Perspectives”.
We are pleased to host this conference as this year we have the privilege and pleasure to host it in association with the Dept. of Family Medicine. Also joining us is the Toxicology Society of South Africa. This will allow the congress to appeal to a much wider scientific audience as it will cover current research concepts in pharmacology and toxicology to current clinical and therapeutic application. Therefore, apart from the scientific program, this year’s congress will be integrated with the 7th Annual Pain Symposium annually hosted by the Dept. of Family Medicine, University of Pretoria.This symposium will address the clinical management of various aspects of pain. Also included in the proceedings this year, will be a clinical symposium that will engage the current treatment perspectives and guidelines on 10 major primary care disorders.
We believe and would hope that it will be beneficial in terms of sharing new ideas and experiences and lead to more practical communications and collaborations between clinical practitioners, academics and researchers, and of course also between universities. This conference will showcase plenary and open discussion forums, panel discussions, formal paper presentation sessions, and workshops in many diverse topics. Thus far, the congress has attracted leading international and national speakers, covering diverse topics relating to clinical medicine and therapeutic strategies, cutting edge pre-clinical research, drug design, formulation, regulation, etc.
The Dept. of Pharmacology, on behalf of the Congress, also invited Dr. H Porchet as the main International Congress speaker:
Dr. Porchet, who holds 3 Specialist Degrees from the Federatio Medica Helvetica (FMH), in Internal Medicine, Clinical Pharmacology and Pharmaceutical Medicine, currently resides in Switzerland. He has an extensive experience in clinical as well as preclinical drug development in numerous therapeutics areas like: CNS – pain– hepatology – infectious diseases – pulmonary diseases – oncology – osteoporosis – endocrinology – reproductive diseases – cardiovascular diseases. He was responsible for the phase I & II clinical development of numerous biotechnology products.This experience was obtained and applied by working as a clinical pharmacologist at the interface of preclinical and clinical development trying to promote translational medicine for more than 25 years in order to achieve a rational and efficient drug development.In order to speed up drug development he is a strong supporter of the use of biomarkers in conjunction with PK-PD modeling, as well as population PK.
From the SASBCP President
Dear colleagues and friends
On behalf of the South African Society for Basic and ClinicalPharmacology (SASBCP * www.sapharmacol.co.za) I wish to invite you toattend the 46th annual congress of the Society, held as a joint meetingwith the Toxicology Society of South Africa (TOXSA) and Dept. of Family Medicine, University of Pretoria.
This meeting promises to bring you sound and cutting edge science, discussing the latest therapeutic strategies in pharmacology, and linking this with the basic science that leads to the discovery of novel drug targets and treatment strategies. This is an ideal opportunity for health practitioners, researchers, pharmaceutical, health and research industry, and policy makers to exchange ideas and to foster sound networking.
Prof Oppel Greeff and his team from Pharmacology at the University of Pretoria have put together an excellent scientific programme, as well asa most enjoyable social programme. We thank them for their effort to make this meeting a great success. We also wish to express our gratitude to several sponsors and exhibitors, supporting the sciences and health care in this country and contributing to the exchange of knowledge.
The SASBCP has a number of projects to drive the pharmacological sciences in South Africa, including an active young scientist and capacity building programme, hosting of the 17th World Congress in Basicand Clinical Pharmacology (WCP2014 * www.wcp2014.org) in Cape Town, July 2014 and the most successful *Pharmacology for Africa* (PharfA *www.iuphar-africa.org) initiative. Whereas these projects offer unique opportunities for networking and exchange of ideas about the latest developments in pharmacological sciences, they also create a platform for us to plough back into communities around us.
The SASBCP looks forward to see you at our 46th annual congress and to discuss the latest knowledge and views with all delegates.
Prof Tiaan Brink